IDIBELL on the media
ICS is the most important national healthcare provider in biomedical research
Annual Report 2014 ICS Annual Report 2014,
Researchers discover an anti-tumor gene loss in cancer of small cell lung
Esteller M. Cancer Research
Described the key role of a protein in blood vessel formation
Knowing the physiology to fight the disease Article reference
IDIBELL licenses to Oxford Immunotec a technology to identify patients at high risk of rejection in kidney transplant
Article reference
A protein conserved from bacteria to human protects against heat stroke
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona have discovered that the LSM-1 protein protects Caernorhabditis elegans against heat stroke. These worms are used as animal model research. Only animals that have a larger amount of this protein survive a drastic temperature rise. The group led by Julian Ceron in IDIBELL specializes in […]
Discovered a cause of mental retardation and autism
The term intellectual disability covers a large number of clinical entities, some with known cause and others of uncertain origin. For example Down syndrome is due to an extra copy of chromosome 21 and Rett syndrome is in part caused by a mutation in the control switch gene called MeCP2. In other cases the mechanisms […]
Researchers discover of a peptide that inhibits tumor progression in breast cancer
Article reference
Discovered a potential treatment option for children with Ewing’s sarcoma
Researchers have tested in mice a combination of two active ingredients that achieves complete remission of the disease in all cases Efficient combination Article reference
Ferrer and IDIBELL develop EPICUP, the first epigenetic test for patients with cancer of unknown origin
About Ferrer
Manel Esteller and Jaume Reventós new members of the Institute of Catalan Studies
The Plenum of the Institute of Catalan Studies (IEC) has announced the addition of five new members. at the Biological Sciences section: Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Institute of Biomedical Research of Bellvitge (IDIBELL); Bonaventura Clotet, head of the HIV Unit of the University Hospital Germans Trias i […]